
Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …

Two months after small drugmaker KaloBios returns from bankruptcy, controversial industry figure Martin Shkreli is no longer a stakeholder in …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

